Aurobindo to buy Sandoz’s dermatology business in US for $1 bn

07 Sep 2018

Aurobindo will pay $900 million for about 300 products, three manufacturing facilities in the US and Eon Labs Inc, a wholly owned unit of Sandoz Inc, besides performance-based payments of $100 million on products in the pipeline

Aurobindo acquires Apotex's business in 5 European countries for €74 mn

16 Jul 2018

Aurobindo and others in the race to buy Novartis portfolio of US assets

12 May 2018

If Aurobindo Pharma is successful in clinching the deal, it would be the largest acquisition of an overseas business by any Indian drug producer, after Lupin's 2015 acquisitions of Gavis Pharmaceuticals and Novel Laboratories for $880 million, in a cash-free and debt deal

Aurobindo in race to acquire generic dermatology business from Novartis

07 May 2018

Aurobindo Pharma acquires Portuguese firm for Rs970 crore

09 Jan 2017

Aurobindo Pharma to buy some commercial products from Teva

26 Nov 2016

Aurobindo, Intas in race for Teva's Irish generics business

29 Aug 2016

Aurobindo Pharma mulls bidding for Teva Pharmaceutical’s $1.5 bn drug portfolio

05 Jul 2016

Aurobindo Phrma to set up plant in S Arabia

11 Jan 2016

Aurobindo Pharma receives US FDA Approval for Norethindrone Acetate Tablets

11 Jan 2016

Stay ahead with Informachine News Trackers! Follow your selected sources, track business news with relevant keywords, and organize seamlessly using labels and bookmarks.

Get the business updates you need, fast, focused, and tailored just for you. Save time, stay informed, and never miss a beat!

Start your free subscription today!

Latest articles on Aurobindo Pharma from Informachine

<div class="content-wrap"><div class="container"><div class="head-title"><h3>Corporate Announcements</h3></div><ul class="nav nav-tabs" role="tablist"><li class="dropdown pull-right tabdrop active"><a class="dropdown-toggle" data-toggle="dropdown" href="#

View details about the software product Informachine News Trackers